NO20090764L - 4-hydroksytiobenzamidderivater og legemidler - Google Patents
4-hydroksytiobenzamidderivater og legemidlerInfo
- Publication number
- NO20090764L NO20090764L NO20090764A NO20090764A NO20090764L NO 20090764 L NO20090764 L NO 20090764L NO 20090764 A NO20090764 A NO 20090764A NO 20090764 A NO20090764 A NO 20090764A NO 20090764 L NO20090764 L NO 20090764L
- Authority
- NO
- Norway
- Prior art keywords
- derivatives
- drugs
- hydroxythiobenzamide
- compounds
- side effects
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title abstract 2
- VDTNKXSVUGXUOJ-UHFFFAOYSA-N chembl2441358 Chemical class NC(=S)C1=CC=C(O)C=C1 VDTNKXSVUGXUOJ-UHFFFAOYSA-N 0.000 title 1
- 230000000694 effects Effects 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C219/14—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the hydroxy groups esterified by a carboxylic acid having the esterifying carboxyl group bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/38—Amides of thiocarboxylic acids
- C07C327/48—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/02—Five-membered rings
- C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Gastroenterology & Hepatology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80763906P | 2006-07-18 | 2006-07-18 | |
| US88718807P | 2007-01-30 | 2007-01-30 | |
| PCT/CA2007/001273 WO2008009118A1 (en) | 2006-07-18 | 2007-07-18 | 4-hydroxythiobenzamide derivatives of drugs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20090764L true NO20090764L (no) | 2009-04-16 |
Family
ID=38956479
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20090764A NO20090764L (no) | 2006-07-18 | 2009-02-17 | 4-hydroksytiobenzamidderivater og legemidler |
| NO20090763A NO342083B1 (no) | 2006-07-18 | 2009-02-17 | Hydrogensulfidderivater av ikke-steroide, antiinflammatoriske legemidler, deres anvendelse for fremstilling av et medikament, samt en farmasøytisk sammensetning derav |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20090763A NO342083B1 (no) | 2006-07-18 | 2009-02-17 | Hydrogensulfidderivater av ikke-steroide, antiinflammatoriske legemidler, deres anvendelse for fremstilling av et medikament, samt en farmasøytisk sammensetning derav |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US8314140B2 (es) |
| EP (2) | EP2057139B1 (es) |
| JP (2) | JP5408719B2 (es) |
| KR (2) | KR101495520B1 (es) |
| AU (2) | AU2007276621B2 (es) |
| BR (2) | BRPI0714330A2 (es) |
| CA (2) | CA2658433C (es) |
| DK (1) | DK2057139T3 (es) |
| ES (1) | ES2437223T3 (es) |
| IL (2) | IL196228A0 (es) |
| MX (2) | MX2009000749A (es) |
| NO (2) | NO20090764L (es) |
| NZ (1) | NZ573996A (es) |
| PL (1) | PL2057139T3 (es) |
| PT (1) | PT2057139E (es) |
| RU (2) | RU2468019C2 (es) |
| WO (2) | WO2008009127A1 (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7741359B2 (en) * | 2005-05-27 | 2010-06-22 | Antibe Therapeutics Inc. | Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs |
| AU2007276621B2 (en) * | 2006-07-18 | 2013-08-01 | Antibe Therapeutics Inc. | Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs |
| ITMI20080382A1 (it) * | 2008-03-07 | 2009-09-08 | Ctg Pharma S R L | Composizioni farmaceutiche oculari |
| ITMI20081167A1 (it) * | 2008-06-26 | 2009-12-27 | Ctg Pharma S R L | Composizioni farmaceutiche per il trattamento di malattie neurodegenerative |
| US8541396B2 (en) | 2009-04-24 | 2013-09-24 | National University Of Singapore | Morpholin-4-ium 4 methoxyphenyl (morpholino) phosphinodithioate (GYY4137) as a novel vasodilator agent |
| WO2011053597A1 (en) * | 2009-10-26 | 2011-05-05 | The University Of Memphis Research Foundation | Pipemidic acid derivative autotaxin inhibitors |
| WO2014015047A1 (en) * | 2012-07-17 | 2014-01-23 | The General Hospital Corporation | Compositions and methods to treat neurodegenerative diseases |
| CA3024556A1 (en) | 2016-05-12 | 2017-11-16 | The Regents Of The University Of Michigan | Ash1l inhibitors and methods of treatment therewith |
| JP2021502388A (ja) | 2017-11-10 | 2021-01-28 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | Ash1l阻害剤及びそれを用いた治療方法 |
| JP2021066660A (ja) * | 2018-02-09 | 2021-04-30 | アピオン・ジャパン有限会社 | Tirap阻害剤 |
| WO2022115952A1 (en) * | 2020-12-03 | 2022-06-09 | Antibe Therapeutics Inc. | [1-(4-chloro-benzoyl)-5-methoxy-2-methyl-1h-indol-3-yl]-acetic acid 4-thiocarbamoyl-phenyl ester for the treatment of a viral infection |
| CN119095591A (zh) * | 2022-02-28 | 2024-12-06 | 安迪贝治疗公司 | 用于治疗与泌尿系统慢性盆腔疼痛综合征相关的疼痛的2-(4-氧代苯基)-苯基丙酸4-硫代氨甲酰基苯基酯 |
| GR1010438B (el) * | 2022-03-21 | 2023-04-06 | UNI-PHARMA ΚΛΕΩΝ ΤΣΕΤΗΣ ΦΑΡΜΑΚΕΥΤΙΚΑ ΕΡΓΑΣΤΗΡΙΑ ΑΒΕΕ με δ.τ. "UNI-PHARMA ABEE", | Φαρμακευτικες ενωσεις που βασιζονται στο συνδυασμο ενος ανταγωνιστη της ισταμινης και ενος δοτη υδροθειου για χρηση στην αντιμετωπιση του κνησμου |
| WO2025076616A1 (en) * | 2023-10-11 | 2025-04-17 | Antibe Therapeutics Inc. | Polymorphic forms of otenaproxesul and compositions and uses thereof |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE612252A (es) | 1961-01-05 | |||
| US4170654A (en) | 1976-02-13 | 1979-10-09 | Merck & Co., Inc. | Antihypertensive compositions containing N-heterocyclicalanines and α- |
| US4112095A (en) | 1976-10-07 | 1978-09-05 | American Cyanamid Company | 6-Phenyl-1,2,4-triazolo[4,3-b]pyridazine hypotensive agents |
| US5663416A (en) | 1990-05-22 | 1997-09-02 | Cortech Inc. | Oxidant sensitive and insensitive aromatic esters as inhibitors of human neutrophil elastase |
| US5214191A (en) | 1990-05-22 | 1993-05-25 | Cortech, Inc. | Oxidant sensitive and insensitive aromatic esters as inhibitors of human neutrophil elastase |
| EP0937711A1 (de) | 1998-02-18 | 1999-08-25 | Roche Diagnostics GmbH | Neue Thiobenzamide, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel |
| IT1311924B1 (it) | 1999-04-13 | 2002-03-20 | Nicox Sa | Composti farmaceutici. |
| IT1314184B1 (it) * | 1999-08-12 | 2002-12-06 | Nicox Sa | Composizioni farmaceutiche per la terapia di condizioni di stressossidativo |
| US6429223B1 (en) | 2000-06-23 | 2002-08-06 | Medinox, Inc. | Modified forms of pharmacologically active agents and uses therefor |
| US7638513B2 (en) | 2004-06-02 | 2009-12-29 | Schering Corporation | Compounds for the treatment of inflammatory disorders |
| EP1630164A1 (en) * | 2004-08-31 | 2006-03-01 | Expotrend Company SA | Pyrazolopyrimidinones as phosphodiesterase inhibitors |
| EP1645288A1 (en) * | 2004-10-07 | 2006-04-12 | CTG Pharma S.r.l. | New nuclear transcription factors regulators |
| CN2757375Y (zh) * | 2004-11-25 | 2006-02-08 | 富士康(昆山)电脑接插件有限公司 | 电子卡连接器 |
| EP1836160A1 (en) * | 2004-12-24 | 2007-09-26 | CTG Pharma S.r.l. | Compounds for treating metabolic syndrome |
| JP2008534475A (ja) | 2005-03-24 | 2008-08-28 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | 6−チアミド置換されたベンゾイミダゾール |
| ITMI20050680A1 (it) * | 2005-04-18 | 2006-10-19 | Ctg Pharma S R L | Nuovi composti anti-infiammatori |
| US20060270635A1 (en) | 2005-05-27 | 2006-11-30 | Wallace John L | Derivatives of 4- or 5-aminosalicylic acid |
| US7498355B2 (en) * | 2005-05-27 | 2009-03-03 | Antibe Therapeutics Inc. | Derivatives of 4- or 5-aminosalicylic acid |
| WO2006125293A1 (en) * | 2005-05-27 | 2006-11-30 | Antibe Therapeutics Inc. | Derivatives of 4- or 5-aminosalicylic acid |
| AU2007276621B2 (en) * | 2006-07-18 | 2013-08-01 | Antibe Therapeutics Inc. | Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs |
-
2007
- 2007-07-18 AU AU2007276621A patent/AU2007276621B2/en active Active
- 2007-07-18 PT PT77639318T patent/PT2057139E/pt unknown
- 2007-07-18 JP JP2009519769A patent/JP5408719B2/ja active Active
- 2007-07-18 US US12/374,273 patent/US8314140B2/en not_active Expired - Fee Related
- 2007-07-18 EP EP07763931.8A patent/EP2057139B1/en active Active
- 2007-07-18 KR KR1020097001128A patent/KR101495520B1/ko not_active Expired - Fee Related
- 2007-07-18 CA CA2658433A patent/CA2658433C/en active Active
- 2007-07-18 JP JP2009519765A patent/JP5529534B2/ja not_active Expired - Fee Related
- 2007-07-18 CA CA002658429A patent/CA2658429A1/en not_active Abandoned
- 2007-07-18 NZ NZ573996A patent/NZ573996A/en not_active IP Right Cessation
- 2007-07-18 RU RU2009105491/04A patent/RU2468019C2/ru active
- 2007-07-18 MX MX2009000749A patent/MX2009000749A/es active IP Right Grant
- 2007-07-18 KR KR1020097001029A patent/KR101450653B1/ko active Active
- 2007-07-18 MX MX2009000750A patent/MX2009000750A/es active IP Right Grant
- 2007-07-18 PL PL07763931T patent/PL2057139T3/pl unknown
- 2007-07-18 AU AU2007276679A patent/AU2007276679B2/en not_active Ceased
- 2007-07-18 EP EP07763921.9A patent/EP2041108B1/en not_active Not-in-force
- 2007-07-18 ES ES07763931.8T patent/ES2437223T3/es active Active
- 2007-07-18 BR BRPI0714330-3A patent/BRPI0714330A2/pt not_active IP Right Cessation
- 2007-07-18 WO PCT/CA2007/001289 patent/WO2008009127A1/en not_active Ceased
- 2007-07-18 RU RU2009105498/04A patent/RU2465271C2/ru not_active IP Right Cessation
- 2007-07-18 WO PCT/CA2007/001273 patent/WO2008009118A1/en not_active Ceased
- 2007-07-18 DK DK07763931.8T patent/DK2057139T3/da active
- 2007-07-18 BR BRPI0714466A patent/BRPI0714466B8/pt active IP Right Grant
-
2008
- 2008-12-28 IL IL196228A patent/IL196228A0/en unknown
- 2008-12-28 IL IL196229A patent/IL196229A/en active IP Right Grant
-
2009
- 2009-02-17 NO NO20090764A patent/NO20090764L/no not_active Application Discontinuation
- 2009-02-17 NO NO20090763A patent/NO342083B1/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20090764L (no) | 4-hydroksytiobenzamidderivater og legemidler | |
| NO20083923L (no) | Pyrazolkinoloner er potente parp-inhibitorer | |
| NO20090295L (no) | Substituerte heteroarylderivater | |
| WO2010129816A3 (en) | Heterocyclic compounds and uses thereof | |
| EA200970447A1 (ru) | Соединения и композиции в качестве ингибиторов протеинкиназы | |
| NO20083669L (no) | 4-aryl-2amino-pyrimidiner eller 4-aryl-2-aminoalkylpyrimidiner som jak-2-modulatorer og fremgangsmater for anvendelse derav | |
| MX2009011210A (es) | Inhibidores de mcl1 de indol 7-no sustituido. | |
| NO20084490L (no) | Nye forbindelser | |
| WO2008131000A3 (en) | 7-substituted indole mcl-1 inhibitors | |
| MY162604A (en) | Heterocyclic compounds and uses thereof | |
| UA98629C2 (ru) | Соединения и способ модуляции киназ | |
| DK1771178T3 (da) | Anvendelse af K-252A og kinaseinhibitorer til forebyggelse eller behandling af HMGB1-assocuerede patologiske tilstande | |
| EA201190158A1 (ru) | Производные бензофуранила для применения в качестве ингибиторов глюкокиназы | |
| MA32508B1 (fr) | Composes organiques | |
| NO20091299L (no) | Substituerte sulfonamidderivater | |
| NO20063925L (no) | Indazolderivater som inhibitorer av hormonsensitiv lipase | |
| NO20090628L (no) | Pyridizinon derivativater | |
| UA112281C2 (uk) | Стабільні інсектицидні композиції і способи їх отримання | |
| NO20075298L (no) | Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists | |
| NO20083726L (no) | Spiroindolinon derivater | |
| MX2009012595A (es) | Derivados de espiroindolinona. | |
| TNSN08191A1 (en) | Kinase inhibitors | |
| BRPI0811617A2 (pt) | derivados de primidina e composições como inibidores de c-kit e pdgfr quinase. | |
| EP2012780A4 (en) | SUBSTITUTED 1H-BENZIMIDAZOLE-4-CARBOXAMIDES AS POTENTE PARP HEMMER | |
| MX2011006334A (es) | Polimorfos de (s)-3-amino-metil-7-(3-hidroxi-propoxi)-3h-benzo-[c] [1,2]-oxaborol-1-ol. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CHAD | Change of the owner's name or address (par. 44 patent law, par. patentforskriften) |
Owner name: ANTIBE HOLDINGS INC, CA |
|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |